ID   ITB3_RAT                Reviewed;         787 AA.
AC   Q8R2H2; M0RCF3;
DT   03-JUL-2019, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   02-OCT-2024, entry version 151.
DE   RecName: Full=Integrin beta-3 {ECO:0000305};
DE   AltName: Full=Platelet membrane glycoprotein IIIa {ECO:0000305};
DE            Short=GPIIIa {ECO:0000305};
DE   Flags: Precursor;
GN   Name=Itgb3 {ECO:0000312|RGD:628868};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|EMBL:CAD29521.1};
RN   [1] {ECO:0000312|EMBL:CAD29521.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar {ECO:0000312|EMBL:CAD29521.1};
RC   TISSUE=Kidney {ECO:0000312|EMBL:CAD29521.1};
RA   Stephan C., Hamacher M.;
RT   "Cloning of the rat integrin beta3 subunit.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=10640428; DOI=10.1006/excr.1999.4765;
RA   Byzova T.V., Kim W., Midura R.J., Plow E.F.;
RT   "Activation of integrin alpha(V)beta(3) regulates cell adhesion and
RT   migration to bone sialoprotein.";
RL   Exp. Cell Res. 254:299-308(2000).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18549786; DOI=10.1016/j.neuron.2008.04.011;
RA   Cingolani L.A., Thalhammer A., Yu L.M., Catalano M., Ramos T.,
RA   Colicos M.A., Goda Y.;
RT   "Activity-dependent regulation of synaptic AMPA receptor composition and
RT   abundance by beta3 integrins.";
RL   Neuron 58:749-762(2008).
RN   [5]
RP   INTERACTION WITH SLC6A4.
RX   PubMed=18317590; DOI=10.1172/jci33374;
RA   Carneiro A.M., Cook E.H., Murphy D.L., Blakely R.D.;
RT   "Interactions between integrin alphaIIbbeta3 and the serotonin transporter
RT   regulate serotonin transport and platelet aggregation in mice and humans.";
RL   J. Clin. Invest. 118:1544-1552(2008).
CC   -!- FUNCTION: Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for
CC       cytotactin, fibronectin, laminin, matrix metalloproteinase-2,
CC       osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and
CC       von Willebrand factor. Integrin alpha-IIB/beta-3 (ITGA2B:ITGB3) is a
CC       receptor for fibronectin, fibrinogen, plasminogen, prothrombin,
CC       thrombospondin and vitronectin. Integrins alpha-IIB/beta-3 and alpha-
CC       V/beta-3 recognize the sequence R-G-D in a wide array of ligands.
CC       Integrin alpha-IIB/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-
CC       G-D-V in fibrinogen gamma chain. Following activation integrin alpha-
CC       IIB/beta-3 brings about platelet/platelet interaction through binding
CC       of soluble fibrinogen. This step leads to rapid platelet aggregation
CC       which physically plugs ruptured endothelial surfaces. Fibrinogen
CC       binding enhances SELP expression in activated platelets (By
CC       similarity). ITGAV:ITGB3 binds to fractalkine (CX3CL1) and acts as its
CC       coreceptor in CX3CR1-dependent fractalkine signaling. ITGAV:ITGB3 binds
CC       to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB
CC       signaling. ITGAV:ITGB3 binds to FGF1 and this binding is essential for
CC       FGF1 signaling. ITGAV:ITGB3 binds to FGF2 and this binding is essential
CC       for FGF2 signaling (By similarity). ITGAV:ITGB3 binds to IGF1 and this
CC       binding is essential for IGF1 signaling (By similarity). ITGAV:ITGB3
CC       binds to IGF2 and this binding is essential for IGF2 signaling (By
CC       similarity). ITGAV:ITGB3 binds to IL1B and this binding is essential
CC       for IL1B signaling (By similarity). ITGAV:ITGB3 binds to PLA2G2A via a
CC       site (site 2) which is distinct from the classical ligand-binding site
CC       (site 1) and this induces integrin conformational changes and enhanced
CC       ligand binding to site 1 (By similarity). ITGAV:ITGB3 acts as a
CC       receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell
CC       adhesion to FBN1 (By similarity). In brain, plays a role in synaptic
CC       transmission and plasticity. Involved in the regulation of the
CC       serotonin neurotransmission, is required to localize to specific
CC       compartments within the synapse the serotonin receptor SLC6A4 and for
CC       an appropriate reuptake of serotonin (By similarity). Controls
CC       excitatory synaptic strength by regulating GRIA2-containing AMPAR
CC       endocytosis, which affects AMPAR abundance and composition
CC       (PubMed:18549786). ITGAV:ITGB3 acts as a receptor for CD40LG (By
CC       similarity). ITGAV:ITGB3 acts as a receptor for IBSP and promotes cell
CC       adhesion and migration to IBSP (PubMed:10640428).
CC       {ECO:0000250|UniProtKB:O54890, ECO:0000250|UniProtKB:P05106,
CC       ECO:0000269|PubMed:10640428, ECO:0000269|PubMed:18549786}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit (By similarity).
CC       Beta-3 (ITGB3) associates with either alpha-IIB (ITGA2B) or alpha-V
CC       (ITGAV). Interacts with FLNB and COMP (By similarity). Interacts with
CC       PDIA6 following platelet stimulation (By similarity). Interacts with
CC       SYK; upon activation by ITGB3 promotes platelet adhesion (By
CC       similarity). Interacts with MYO10 (By similarity). Interacts with DAB2.
CC       Interacts with FERMT2. Integrin ITGAV:ITGB3 interacts with FBLN5 (via
CC       N-terminus) (By similarity). Interacts with EMP2; regulates the levels
CC       of the heterodimer ITGA5:ITGB3 integrin expression on the plasma
CC       membrane (By similarity). ITGAV:ITGB3 interacts with CCN3 (By
CC       similarity). ITGAV:ITGB3 and ITGA2B:ITGB3 interact with SELP (via C-
CC       type lectin domain); the interaction mediates cell-cell interaction and
CC       adhesion (By similarity). ITGAV:ITGB3 interacts with AGRA2 (By
CC       similarity). ITGAV:ITGB3 is found in a ternary complex with CX3CR1 and
CC       CX3CL1. ITGAV:ITGB3 is found in a ternary complex with NRG1 and ERBB3.
CC       ITGAV:ITGB3 is found in a ternary complex with FGF1 and FGFR1.
CC       ITGAV:ITGB3 interacts with FGF2; it is likely that FGF2 can
CC       simultaneously bind ITGAV:ITGB3 and FGF receptors (By similarity).
CC       ITGAV:ITGB3 binds to IL1B (By similarity). ITGAV:ITGB3 is found in a
CC       ternary complex with IGF1 and IGF1R (By similarity). ITGAV:ITGB3
CC       interacts with IGF2 (By similarity). ITGAV:ITGB3 interacts with FBN1
CC       (By similarity). ITGAV:ITGB3 interacts with CD9, CD81 and CD151 (via
CC       second extracellular domain) (By similarity). Interacts (via the
CC       allosteric site (site 2)) with CXCL12 in a CXCR4-independent manner (By
CC       similarity). Interacts with MXRA8/DICAM; the interaction inhibits
CC       ITGAV:ITGB3 heterodimer formation (By similarity). ITGAV:ITGB3
CC       interacts with PTN. Forms a complex with PTPRZ1 and PTN that stimulates
CC       endothelial cell migration through ITGB3 Tyr-772 phosphorylation (By
CC       similarity). ITGAV:ITGB3 interacts with SLC6A4 (By similarity).
CC       Interacts with SLC6A4 (via C-terminus); this interaction regulates
CC       SLC6A4 trafficking (PubMed:18317590). ITGA2B:ITGB3 interacts with
CC       PPIA/CYPA; the interaction is ROS and PPIase activity-dependent and is
CC       increased in the presence of thrombin (By similarity). Interacts with
CC       tensin TNS3; TNS3 also interacts with PEAK1, thus acting as an adapter
CC       molecule to bridge the association of PEAK1 with ITGB3 (By similarity).
CC       {ECO:0000250|UniProtKB:O54890, ECO:0000250|UniProtKB:P05106,
CC       ECO:0000269|PubMed:18317590}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P05106};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P05106}.
CC       Cell projection, lamellipodium membrane {ECO:0000250|UniProtKB:P05106}.
CC       Cell junction, focal adhesion {ECO:0000250|UniProtKB:O54890}.
CC       Postsynaptic cell membrane {ECO:0000269|PubMed:18549786}; Single-pass
CC       type I membrane protein {ECO:0000305}. Synapse
CC       {ECO:0000250|UniProtKB:O54890}.
CC   -!- DOMAIN: The VWFA domain (or beta I domain) contains three cation-
CC       binding sites: the ligand-associated metal ion-binding site (LIMBS or
CC       SyMBS), the metal ion-dependent adhesion site (MIDAS), and the adjacent
CC       MIDAS site (ADMIDAS). This domain is also part of the ligand-binding
CC       site. {ECO:0000250|UniProtKB:P05106}.
CC   -!- PTM: Phosphorylated on tyrosine residues in response to thrombin-
CC       induced platelet aggregation. Probably involved in outside-in
CC       signaling. {ECO:0000250|UniProtKB:P05106}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ440952; CAD29521.1; -; mRNA.
DR   EMBL; AABR07030536; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030538; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030539; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030543; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07030544; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; PN0509; PN0509.
DR   RefSeq; NP_714942.1; NM_153720.1.
DR   AlphaFoldDB; Q8R2H2; -.
DR   SMR; Q8R2H2; -.
DR   CORUM; Q8R2H2; -.
DR   STRING; 10116.ENSRNOP00000067271; -.
DR   BindingDB; Q8R2H2; -.
DR   ChEMBL; CHEMBL4296069; -.
DR   GlyCosmos; Q8R2H2; 5 sites, No reported glycans.
DR   GlyGen; Q8R2H2; 5 sites.
DR   PhosphoSitePlus; Q8R2H2; -.
DR   Ensembl; ENSRNOT00000073350.3; ENSRNOP00000067271.3; ENSRNOG00000048449.3.
DR   GeneID; 29302; -.
DR   KEGG; rno:29302; -.
DR   AGR; RGD:628868; -.
DR   CTD; 3690; -.
DR   RGD; 628868; Itgb3.
DR   GeneTree; ENSGT01110000267169; -.
DR   HOGENOM; CLU_011772_0_1_1; -.
DR   InParanoid; Q8R2H2; -.
DR   OMA; AKWDTTH; -.
DR   OrthoDB; 5475862at2759; -.
DR   PhylomeDB; Q8R2H2; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-1566948; Elastic fibre formation.
DR   Reactome; R-RNO-210990; PECAM1 interactions.
DR   Reactome; R-RNO-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-2173789; TGF-beta receptor signaling activates SMADs.
DR   Reactome; R-RNO-3000170; Syndecan interactions.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-RNO-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-445144; Signal transduction by L1.
DR   Reactome; R-RNO-5674135; MAP2K and MAPK activation.
DR   PRO; PR:Q8R2H2; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   GO; GO:0071133; C:alpha9-beta1 integrin-ADAM8 complex; ISO:RGD.
DR   GO; GO:0035868; C:alphav-beta3 integrin-HMGB1 complex; ISO:RGD.
DR   GO; GO:0035867; C:alphav-beta3 integrin-IGF-1-IGF1R complex; ISO:RGD.
DR   GO; GO:0035866; C:alphav-beta3 integrin-PKCalpha complex; ISO:RGD.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0031527; C:filopodium membrane; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0070442; C:integrin alphaIIb-beta3 complex; ISO:RGD.
DR   GO; GO:0034683; C:integrin alphav-beta3 complex; ISO:RGD.
DR   GO; GO:0008305; C:integrin complex; IDA:RGD.
DR   GO; GO:0031258; C:lamellipodium membrane; ISO:RGD.
DR   GO; GO:0042470; C:melanosome; ISO:RGD.
DR   GO; GO:0031528; C:microvillus membrane; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0032587; C:ruffle membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0097060; C:synaptic membrane; ISO:RGD.
DR   GO; GO:0019960; F:C-X3-C chemokine binding; IEA:Ensembl.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0050840; F:extracellular matrix binding; ISO:RGD.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IEA:Ensembl.
DR   GO; GO:0001968; F:fibronectin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0031994; F:insulin-like growth factor I binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0038132; F:neuregulin binding; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; ISO:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:RGD.
DR   GO; GO:0043184; F:vascular endothelial growth factor receptor 2 binding; ISO:RGD.
DR   GO; GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0043277; P:apoptotic cell clearance; ISO:RGD.
DR   GO; GO:0072378; P:blood coagulation, fibrin clot formation; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; TAS:RGD.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISO:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0031589; P:cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0007044; P:cell-substrate junction assembly; ISO:RGD.
DR   GO; GO:1990314; P:cellular response to insulin-like growth factor stimulus; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; ISO:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007566; P:embryo implantation; IEP:RGD.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0098880; P:maintenance of postsynaptic specialization structure; IDA:SynGO.
DR   GO; GO:0048333; P:mesodermal cell differentiation; ISO:RGD.
DR   GO; GO:0050919; P:negative chemotaxis; ISO:RGD.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:RGD.
DR   GO; GO:0010888; P:negative regulation of lipid storage; ISO:RGD.
DR   GO; GO:0032369; P:negative regulation of lipid transport; ISO:RGD.
DR   GO; GO:0050748; P:negative regulation of lipoprotein metabolic process; ISO:RGD.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; ISO:RGD.
DR   GO; GO:0030168; P:platelet activation; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:1900731; P:positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway; IMP:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:RGD.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IMP:RGD.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; IMP:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0072126; P:positive regulation of glomerular mesangial cell proliferation; IMP:RGD.
DR   GO; GO:0002687; P:positive regulation of leukocyte migration; IMP:RGD.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:2000406; P:positive regulation of T cell migration; ISO:RGD.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:1903053; P:regulation of extracellular matrix organization; ISO:RGD.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0150054; P:regulation of postsynaptic neurotransmitter receptor diffusion trapping; IDA:SynGO.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; ISO:RGD.
DR   GO; GO:0032880; P:regulation of protein localization; ISS:UniProtKB.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IDA:RGD.
DR   GO; GO:0051611; P:regulation of serotonin uptake; ISS:UniProtKB.
DR   GO; GO:1901163; P:regulation of trophoblast cell migration; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0036119; P:response to platelet-derived growth factor; IEP:RGD.
DR   GO; GO:0014909; P:smooth muscle cell migration; ISO:RGD.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:0046718; P:symbiont entry into host cell; IEA:Ensembl.
DR   Gene3D; 4.10.1240.30; -; 1.
DR   Gene3D; 1.20.5.100; Cytochrome c1, transmembrane anchor, C-terminal; 1.
DR   Gene3D; 2.10.25.10; Laminin; 4.
DR   Gene3D; 3.30.1680.10; ligand-binding face of the semaphorins, domain 2; 1.
DR   Gene3D; 2.60.40.1510; ntegrin, alpha v. Chain A, domain 3; 1.
DR   Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR040622; I-EGF_1.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; INTEGRIN BETA SUBUNIT; 1.
DR   PANTHER; PTHR10082:SF25; INTEGRIN BETA-3; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF18372; I-EGF_1; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 2.
DR   SUPFAM; SSF69687; Integrin beta tail domain; 1.
DR   SUPFAM; SSF69179; Integrin domains; 1.
DR   SUPFAM; SSF103575; Plexin repeat; 1.
DR   SUPFAM; SSF53300; vWA-like; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell junction; Cell membrane; Cell projection;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Integrin; Magnesium;
KW   Membrane; Metal-binding; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Repeat; Signal; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..787
FT                   /note="Integrin beta-3"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5004312362"
FT   TOPO_DOM        27..717
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        718..738
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        739..787
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          29..75
FT                   /note="PSI"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          134..376
FT                   /note="VWFA"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DOMAIN          435..497
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DOMAIN          498..547
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DOMAIN          548..584
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DOMAIN          585..628
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   REGION          202..209
FT                   /note="CX3CL1-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   REGION          202..209
FT                   /note="Involved in CX3CL1-, NRG1-, FGF1- and IGF1-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   REGION          292..312
FT                   /note="CX3CL1-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   MOTIF           776..782
FT                   /note="LIR"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         146
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /note="in MIDAS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         148
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /note="in ADMIDAS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         148
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /note="in MIDAS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         151
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /note="in ADMIDAS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         152
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /note="in ADMIDAS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         183
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /note="in LIMBS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         240
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /note="in LIMBS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         242
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /note="in LIMBS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         244
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /note="in LIMBS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         245
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /note="in LIMBS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /note="in MIDAS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         276
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /note="in ADMIDAS binding site and liganded-open
FT                   conformation"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   BINDING         276
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /note="in LIMBS binding site"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   MOD_RES         766
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O54890"
FT   MOD_RES         772
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   MOD_RES         778
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   MOD_RES         784
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        396
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        477
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        584
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        679
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        30..48
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        38..460
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        41..63
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        51..74
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        202..209
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        257..298
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        399..411
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        431..458
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        462..482
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        473..485
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        487..496
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        498..528
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        511..526
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        520..531
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        533..546
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        548..569
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        553..567
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        561..572
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        574..583
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        585..608
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        592..606
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        600..611
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        613..623
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        626..629
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        633..680
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        639..660
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        642..656
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
FT   DISULFID        688..712
FT                   /evidence="ECO:0000250|UniProtKB:P05106"
SQ   SEQUENCE   787 AA;  86930 MW;  C67826118411FE95 CRC64;
     MRTRRPGQLW ATLLALGALA GVVVGESNIC TTRGVNSCQQ CLAVSPVCAW CSDESLPQNS
     PRCNLKKNLL KDKCSPESIE FPVSEAQILE ALPLSSKGSG DSAQITQVSP QRIALRLRPD
     DSKIFSLQVR QVEDYPVDIY YLMDLSFSMK DDLSSIQTLG TKLASQMRKL TSNLRIGFGA
     FVDKPVSPYM FISPPQAIKN PCYTMKSTCL PMFGYKHVLT LTDQVTRFND EVKKQSVSRN
     RDAPEGGFDA IMQATVCDEK IGWRNDASHL LVFTTDAKTH IALDGRLAGI VLPNDGRCHI
     GPDNHYSAST TMDYPSLGLM TEKLSQKNIN LIFAVTENVV SLYQNYSELI PGTTVGVLSD
     DSSNVLQLIV DAYGKIRSKV ELEVRDLPEE LSLSFNATCL NNEVIPGLKS CVGLKIGDTV
     SFSIEAKVRG CPQQKEQSFT IKPVGFKDSL TVQVTFDCDC DCQAFAQPLS PRCNNGNGTF
     ECGVCRCDQG WLGSMCECSE EDYRPSQQEE CSPKEGQPIC SQRGECLCGQ CVCHSSDFGK
     ITGKYCECDD FSCVRYKGEM CSGHGQCNCG DCVCDSDWTG YYCNCTTRTD TCMSTNGLLC
     SGRGNCECGS CVCVQPGSYG DTCEKCPTCP DACSFKKDCV ECKKFNRGKL HEENNCNRFC
     RDDIELVKEL TDTGKNAVNC TYKNEDDCVV RFQYYEDSSG RAVLYVVEEP ECPKGPDILV
     VLLSVMGAIL LIGLATLLIW KLLITIHDRK EFAKFEEERA RAKWDTANNP LYKEATSTFT
     NITYRGT
//
